Karen J. Wilson - Jan 14, 2025 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Director
Signature
Karen J. Wilson
Stock symbol
SER
Transactions as of
Jan 14, 2025
Transactions value $
$0
Form type
4
Date filed
1/15/2025, 04:23 PM
Previous filing
Jan 2, 2025
Next filing
Feb 18, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SER Stock Option (right to buy) Award $0 +40K $0.00 40K Jan 14, 2025 Common Stock 40K $4.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest in substantially equal yearly installments beginning on the first anniversary of the grant date such that the stock options shall be fully vested on the third anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.